VMS stands for vasomotor symptoms, the medical term for hot flashes and night sweats that happen during menopause. Up to 80% of women experience VMS during the menopausal transition, making them the most common and recognizable symptoms of menopause. If you’ve seen “VMS” on a health website or heard it from a doctor, this is what it refers to.
What VMS Feels Like
A hot flash is a sudden wave of intense heat, typically felt around the head, neck, chest, and upper back. Your skin may flush red, and you’ll often break into a sweat that can range from mild dampness to drenching. The sensation usually lasts a few minutes but can feel much longer when it strikes during a meeting, a meal, or sleep.
Night sweats are the same phenomenon happening while you’re asleep. They can soak through pajamas and sheets, waking you up and making it difficult to fall back asleep. Over time, repeated nighttime episodes take a real toll on sleep quality and daytime energy.
Why VMS Happen
Your brain has a built-in thermostat: a cluster of neurons in the hypothalamus that keeps your body temperature within a narrow comfortable range. Estrogen normally helps keep these neurons in check. During menopause, as estrogen levels drop, these temperature-regulating neurons become overstimulated. The comfortable range narrows dramatically, so even tiny shifts in body temperature can trigger the brain to launch a full cooling response: blood vessels near the skin dilate, your heart rate increases, and sweat glands activate. The result is a hot flash, even though your core temperature hasn’t actually risen much.
How Long VMS Last
VMS are not a brief phase. A major longitudinal study published in JAMA Internal Medicine found that the median total duration of frequent VMS was 7.4 years. After the final menstrual period, symptoms persisted for a median of 4.5 years. More than half of the women in the study experienced frequent hot flashes for over seven years.
When symptoms started earlier in the menopausal transition, they lasted significantly longer. Women who first reported frequent VMS while still premenopausal or in early perimenopause had a median duration exceeding 11.8 years. Those whose symptoms didn’t begin until after their final period had a shorter course of about 3.5 years.
Race and ethnicity also played a role. African American women reported the longest median duration at 10.1 years, while Chinese American women tended to have shorter symptom timelines. Higher stress levels, anxiety, depressive symptoms, and greater sensitivity to physical symptoms were all linked to longer-lasting VMS.
VMS Prevalence and Timing
Hot flashes and night sweats are uncommon before perimenopause begins, then increase steadily. They peak right around the final menstrual period. In the first two years after that final period, roughly three out of four women experience VMS. From there, symptoms decline slowly, typically taking 8 to 10 years to return to pre-menopause levels. The daily frequency varies widely: some women have a few mild episodes per week, while others experience dozens of moderate to severe hot flashes each day.
The Link to Heart Health
VMS are more than a comfort issue. A pooled analysis of six prospective studies found that the severity of hot flashes and night sweats was associated with a higher risk of cardiovascular disease. Women with severe VMS had roughly double the risk of a cardiovascular event compared to women without symptoms. Frequent night sweats carried particular risk: women who reported night sweats “often” had a 29% higher risk of cardiovascular disease than those who didn’t experience them.
Both early-onset and late-onset VMS were associated with increased cardiovascular risk. Women who had both severe hot flashes and severe night sweats faced a 55% higher risk compared to symptom-free women. This doesn’t mean VMS cause heart disease directly, but it does suggest they may be a signal of underlying vascular changes worth paying attention to.
Hormone Therapy for VMS
Menopausal hormone therapy remains the most effective treatment for VMS, reducing symptoms by about 75% at standard doses and around 65% at lower doses. It provides the greatest benefit when started during perimenopause or within the first 10 years after menopause, ideally before age 60. This timing matters because the cardiovascular safety profile is most favorable in that window.
Hormone therapy comes in several forms: oral tablets, skin patches, and gels. The choice depends on your health history and preferences. Women who still have a uterus need a progestogen alongside estrogen to protect the uterine lining. Those who’ve had a hysterectomy can use estrogen alone. Your doctor will typically start with the lowest effective dose.
Non-Hormonal Treatment Options
For women who can’t or prefer not to use hormones, the FDA approved a non-hormonal option in 2023 called fezolinetant (sold as Veozah). It works by blocking a specific receptor in the brain’s temperature-control center, targeting the same overactive neurons that drive hot flashes. It’s the first drug in its class and was designed specifically for moderate to severe VMS.
Other non-hormonal options that doctors sometimes prescribe include certain antidepressants and anti-seizure medications that can reduce hot flash frequency, though these are used off-label for VMS.
Triggers That Make VMS Worse
Certain everyday habits can increase the frequency and intensity of hot flashes. Alcohol is one of the most consistent triggers. Drinking three or more times per week was associated with roughly triple the odds of worsened VMS in one analysis. Spicy foods are another well-documented trigger.
Stress has a direct impact on hot flash frequency and intensity. Women reporting higher perceived stress at the onset of VMS experienced longer and more severe symptom courses. Caffeine, hot beverages, warm environments, and tight clothing are commonly reported triggers as well. Identifying your personal triggers through a simple diary can help you reduce the number of episodes you experience each day, particularly for mild to moderate symptoms.